10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0000897101-11-001376`
Period End Date	20110630
Filing Date	20110810
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	stj-20110702.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 68 Cash Flow Statement 63

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$39.10M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$35.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$500.34M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$667.05M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$832.82M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $39,101 at July 2, 2011 and $35,354 at January 1, 2011	`AccountsReceivableNetCurrent`	$1.44B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $39,101 at July 2, 2011 and $35,354 at January 1, 2011	`AccountsReceivableNetCurrent`	$1.33B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$667.54M	USD	Point-in-time
Inventories	`InventoryNet`	$699.16M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$196.60M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$204.21M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$216.46M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$178.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	329.22M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	329.02M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.91B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.36B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.22B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.39B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	329.02M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	329.22M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.01B	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$900.42M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.38B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.32B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Goodwill	`Goodwill`	$2.98B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$945.39M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$987.06M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$427.48M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$387.71M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.10B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$8.57B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$80.47M	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$79.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$297.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$166.08M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$69.14M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$320.32M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$322.84M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$367.81M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$319.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.02B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.01B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.43B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.49B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$303.31M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$310.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$464.06M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$435.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.19B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.26B	USD	Point-in-time
Commitments and Contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 329,217,266 and 329,018,166 shares issued and outstanding at July 2, 2011 and January 1, 2011, respectively)	`CommonStockValueOutstanding`	$32.92M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 329,217,266 and 329,018,166 shares issued and outstanding at July 2, 2011 and January 1, 2011, respectively)	`CommonStockValueOutstanding`	$32.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$275.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$156.13M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.33B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.10B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$68.90M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$177.57M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$15.11M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$15.82M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.84B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.37B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$8.57B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$9.10B	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$2.57B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$2.82B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$1.45B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.31B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$383.88M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$345.30M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$666.47M	USD	2 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$748.32M	USD	2 Qtrs
Special charges	`SpecialCharges`	$11.05M	USD	1 Quarter
Special charges	`SpecialCharges`	$11.05M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$759.37M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$394.92M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$666.47M	USD	2 Qtrs
Total cost of sales	`CostOfGoodsSold`	$345.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.06B	USD	2 Qtrs
Gross profit	`GrossProfit`	$967.47M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.91B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.05B	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$890.90M	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.03B	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$447.61M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$513.84M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$155.10M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$306.33M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$352.07M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$176.33M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$-4.40M	USD	2 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$-4.40M	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$32.17M	USD	2 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$32.17M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$647.10M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$325.08M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$364.75M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$710.76M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-20.23M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-40.55M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-51.47M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-25.01M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$595.64M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$344.52M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$670.21M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$300.07M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$90.48M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$177.61M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$59.18M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$121.31M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$254.04M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$240.89M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$474.32M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$492.61M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$1.45	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.73	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.78	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.51	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.72	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.43	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.77	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.50	USD	2 Qtrs
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.21	USD	1 Quarter
Cash dividends declared per share:	`CommonStockDividendsPerShareDeclared`	$0.42	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.94M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	328.62M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.92M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.11M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.31M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	330.76M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	332.63M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	328.68M	shares	2 Qtrs

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$474.32M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$492.61M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$254.04M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$240.89M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$148.79M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$115.36M	USD	2 Qtrs
Amortization of debt discount (premium)	`AmortizationOfDebtDiscountPremium`	$454.00K	USD	2 Qtrs
Amortization of debt discount (premium)	`AmortizationOfDebtDiscountPremium`	$-2.70M	USD	2 Qtrs
Inventory step-up amortization	`InventoryStepUpAmortization`	$29.44M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$38.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$36.44M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$8.52M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$8.00M	USD	2 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$-4.40M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$-4.40M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-16.58M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$11.39M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$48.22M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$135.36M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$48.07M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$19.86M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-44.03M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$38.14M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$43.62M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-57.01M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$13.84M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$12.11M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-3.13M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$495.38M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$583.82M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$162.62M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$145.75M	USD	2 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$135.60M	USD	2 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$19.49M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$16.15M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-297.50M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-182.12M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$65.19M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$241.59M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$8.52M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$8.00M	USD	2 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$309.20M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$68.65M	USD	2 Qtrs
Issuances/payments of commercial paper borrowings, net	`ProceedsFromRepaymentsOfShortTermDebt`	$46.30M	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$671.09M	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$655.72M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-81.45M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$88.56M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$12.22M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-12.31M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$274.13M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$332.48M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$500.34M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$667.05M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$832.82M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$500.34M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$667.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$832.82M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.